Eric G Berger - Publications

Affiliations: 
Universität Zürich, Zürich, ZH, Switzerland 

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Lecca MR, Maag C, Berger EG, Hennet T. Fibrotic response in fibroblasts from congenital disorders of glycosylation. Journal of Cellular and Molecular Medicine. 15: 1788-96. PMID 21029365 DOI: 10.1111/J.1582-4934.2010.01187.X  0.627
2008 Schaub BE, Berger EG, Rohrer J. Dissection of a novel molecular determinant mediating Golgi to trans -Golgi network transition Cellular and Molecular Life Sciences. 65: 3677-3687. PMID 18953688 DOI: 10.1007/S00018-008-8446-Y  0.3
2006 Schaub BE, Berger B, Berger EG, Rohrer J. Transition of galactosyltransferase 1 from trans-Golgi cisterna to the trans-Golgi network is signal mediated. Molecular Biology of the Cell. 17: 5153-62. PMID 17021253 DOI: 10.1091/Mbc.E06-08-0665  0.31
2005 Lecca MR, Wagner U, Patrignani A, Berger EG, Hennet T. Genome-wide analysis of the unfolded protein response in fibroblasts from congenital disorders of glycosylation type-I patients. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 240-2. PMID 15545299 DOI: 10.1096/Fj.04-2397Fje  0.651
2004 Kweon HS, Beznoussenko GV, Micaroni M, Polishchuk RS, Trucco A, Martella O, Di Giandomenico D, Marra P, Fusella A, Di Pentima A, Berger EG, Geerts WJC, Koster AJ, Burger KNJ, Luini A, et al. Golgi enzymes are enriched in perforated zones of Golgi cisternae but are depleted in COPI vesicles Molecular Biology of the Cell. 15: 4710-4724. PMID 15282336 DOI: 10.1091/Mbc.E03-12-0881  0.31
2004 Frank CG, Grubenmann CE, Eyaid W, Berger EG, Aebi M, Hennet T. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. American Journal of Human Genetics. 75: 146-50. PMID 15148656 DOI: 10.1086/422367  0.67
2004 Grubenmann CE, Frank CG, Hülsmeier AJ, Schollen E, Matthijs G, Mayatepek E, Berger EG, Aebi M, Hennet T. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. Human Molecular Genetics. 13: 535-42. PMID 14709599 DOI: 10.1093/Hmg/Ddh050  0.67
2003 Berger EG, Rohrer J. Galactosyltransferase—still up and running Biochimie. 85: 261-274. PMID 12770765 DOI: 10.1016/S0300-9084(03)00008-7  0.338
2003 Schenk B, Imbach T, Frank CG, Grubenmann CE, Raymond GV, Hurvitz H, Raas-Rotschild A, Luder AS, Jaeken J, Berger EG, Matthijs G, Hennet T, Aebi M, Jaeken J. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If Journal of Clinical Investigation. 111: 925-925. DOI: 10.1172/Jci13419C1  0.617
2002 Grubenmann CE, Frank CG, Kjaergaard S, Berger EG, Aebi M, Hennet T. ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg. Human Molecular Genetics. 11: 2331-9. PMID 12217961 DOI: 10.1093/Hmg/11.19.2331  0.667
2002 Hansske B, Thiel C, Lübke T, Hasilik M, Höning S, Peters V, Heidemann PH, Hoffmann GF, Berger EG, von Figura K, Körner C. Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. The Journal of Clinical Investigation. 109: 725-33. PMID 11901181 DOI: 10.1172/JCI14010  0.358
2002 Berger EG. Ectopic localizations of Golgi glycosyltransferases. Glycobiology. 12: 29R-36R. PMID 11886838 DOI: 10.1093/Glycob/12.2.29R  0.302
2002 Malissard M, Dinter A, Berger EG, Hennet T. Functional assignment of motifs conserved in beta 1,3-glycosyltransferases. European Journal of Biochemistry. 269: 233-9. PMID 11784317 DOI: 10.1046/J.0014-2956.2001.02644.X  0.656
2002 Schenk B, Imbach T, Frank CG, Grubenmann CE, Raymond GV, Hurvitz H, Korn-Lubetzki I, Revel-Vik S, Raas-Rotschild A, Luder AS, Jaeken J, Berger EG, Matthijs G, Hennet T, Aebi M. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. The Journal of Clinical Investigation. 108: 1687-95. PMID 11733564 DOI: 10.1172/Jci13419  0.673
2001 Brinkmann N, Malissard M, Ramuz M, Römer U, Schumacher T, Berger EG, Elling L, Wandrey C, Liese A. Chemo-enzymatic synthesis of the Galili epitope Gal(alpha)(1-->3)Galbeta(1-->4)GlcNAc on a homogeneously soluble PEG polymer by a multi-enzyme system. Bioorganic & Medicinal Chemistry Letters. 11: 2503-6. PMID 11549456 DOI: 10.1016/S0960-894X(01)00474-7  0.302
2001 Malissard M, Berger EG. Improving solubility of catalytic domain of human beta-1,4-galactosyltransferase 1 through rationally designed amino acid replacements. European Journal of Biochemistry. 268: 4352-8. PMID 11488931 DOI: 10.1046/J.1432-1327.2001.02357.X  0.382
2001 Berger EG, Berger B, Höchli M, Dinter A. Colocalization of beta 1,4galactosyltransferase with mannose 6-phosphate receptor in monensin-induced TGN-derived structures. Histochemistry and Cell Biology. 115: 157-68. PMID 11444150 DOI: 10.1007/S004180000231  0.33
2001 Legaigneur P, Breton C, El Battari A, Guillemot JC, Auge C, Malissard M, Berger EG, Ronin C. Exploring the acceptor substrate recognition of the human beta-galactoside alpha 2,6-sialyltransferase. The Journal of Biological Chemistry. 276: 21608-17. PMID 11279145 DOI: 10.1074/Jbc.M100860200  0.428
2000 Imbach T, Grünewald S, Schenk B, Burda P, Schollen E, Wevers RA, Jaeken J, de Klerk JB, Berger EG, Matthijs G, Aebi M, Hennet T. Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic. Human Genetics. 106: 538-45. PMID 10914684 DOI: 10.1007/S004390000293  0.632
2000 Schnyder-Candrian S, Borsig L, Moser R, Berger EG. Localization of α1,3-fucosyltransferase VI in Weibel–Palade bodies of human endothelial cells Proceedings of the National Academy of Sciences of the United States of America. 97: 8369-8374. PMID 10900002 DOI: 10.1073/Pnas.97.15.8369  0.359
2000 Zhou D, Henion TR, Jungalwala FB, Berger EG, Hennet T. The beta 1,3-galactosyltransferase beta 3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase. The Journal of Biological Chemistry. 275: 22631-4. PMID 10837462 DOI: 10.1074/Jbc.C000263200  0.722
2000 Imbach T, Schenk B, Schollen E, Burda P, Stutz A, Grunewald S, Bailie NM, King MD, Jaeken J, Matthijs G, Berger EG, Aebi M, Hennet T. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. The Journal of Clinical Investigation. 105: 233-9. PMID 10642602 DOI: 10.1172/Jci8691  0.675
2000 Zhou D, Malissard M, Berger EG, Hennet T. Secretion and purification of recombinant beta1-4 galactosyltransferase from insect cells using pFmel-protA, a novel transposition-based baculovirus transfer vector. Archives of Biochemistry and Biophysics. 374: 3-7. PMID 10640389 DOI: 10.1006/Abbi.1999.1622  0.716
2000 Malissard M, Zeng S, Berger EG. Expression of functional soluble forms of human beta-1, 4-galactosyltransferase I, alpha-2,6-sialyltransferase, and alpha-1, 3-fucosyltransferase VI in the methylotrophic yeast Pichia pastoris. Biochemical and Biophysical Research Communications. 267: 169-73. PMID 10623593 DOI: 10.1006/Bbrc.1999.1946  0.374
2000 Dinter A, Zeng S, Berger B, Berger EG. Glycosylation engineering in Chinese hamster ovary cells using tricistronic vectors Biotechnology Letters. 22: 25-30. DOI: 10.1023/A:1005600222635  0.353
1999 Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, Hennet T, Imbach T, Stutz A, Bjursell C, Uller A, Wahlström JG, Briones P, Cardo E, Clayton P, et al. Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconjugate Journal. 16: 669-71. PMID 11003549 DOI: 10.1023/A:1017249723165  0.617
1999 Donovan RS, Datti A, Baek MG, Wu Q, Sas IJ, Korczak B, Berger EG, Roy R, Dennis JW. A solid-phase glycosyltransferase assay for high-throughput screening in drug discovery research. Glycoconjugate Journal. 16: 607-15. PMID 10972139 DOI: 10.1023/A:1007024916491  0.345
1999 Zeng S, Gallego RG, Dinter A, Malissard M, Kamerling JP, Vliegenthart JF, Berger EG. Complete enzymic synthesis of the mucin-type sialyl Lewis x epitope, involved in the interaction between PSGL-1 and P-selectin. Glycoconjugate Journal. 16: 487-97. PMID 10815985 DOI: 10.1023/A:1007065803554  0.363
1999 Elling L, Zervosen A, Gallego RG, Nieder V, Malissard M, Berger EG, Vliegenthart JF, Kamerling JP. UDP-N-Acetyl-alpha-D-glucosamine as acceptor substrate of beta-1,4-galactosyltransferase. Enzymatic synthesis of UDP-N-acetyllactosamine. Glycoconjugate Journal. 16: 327-36. PMID 10619705 DOI: 10.1023/A:1007039825505  0.364
1999 Malissard M, Zeng S, Berger EG. The yeast expression system for recombinant glycosyltransferases. Glycoconjugate Journal. 16: 125-39. PMID 10612412 DOI: 10.1023/A:1007055525789  0.35
1999 Borsig L, Imbach T, Höchli M, Berger EG. α1,3Fucosyltransferase VI is expressed in HepG2 cells and codistributed with β1,4galactosyltransferase I in the Golgi apparatus and monensin-induced swollen vesicles Glycobiology. 9: 1273-1280. PMID 10536043 DOI: 10.1093/Glycob/9.11.1273  0.344
1999 Zhou D, Berger EG, Hennet T. Molecular cloning of a human UDP-galactose:GlcNAcbeta1,3GalNAc beta1, 3 galactosyltransferase gene encoding an O-linked core3-elongation enzyme. European Journal of Biochemistry. 263: 571-6. PMID 10406968 DOI: 10.1046/J.1432-1327.1999.00541.X  0.733
1999 Imbach T, Burda P, Kuhnert P, Wevers RA, Aebi M, Berger EG, Hennet T. A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. Proceedings of the National Academy of Sciences of the United States of America. 96: 6982-7. PMID 10359825 DOI: 10.1073/Pnas.96.12.6982  0.663
1999 Zhou D, Dinter A, Gutiérrez Gallego R, Kamerling JP, Vliegenthart JF, Berger EG, Hennet T. A beta-1,3-N-acetylglucosaminyltransferase with poly-N-acetyllactosamine synthase activity is structurally related to beta-1,3-galactosyltransferases. Proceedings of the National Academy of Sciences of the United States of America. 96: 406-11. PMID 9892646 DOI: 10.1073/Pnas.96.2.406  0.734
1998 Keusch J, Lydyard PM, Berger EG, Delves PJ. B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis. Glycoconjugate Journal. 15: 1093-1097. PMID 10386894 DOI: 10.1023/A:1006957711557  0.331
1998 Keusch J, Panayotou G, Malissard M, Berger EG, Appert HE, Lydyard PM, Delves PJ. Antibody recognition of epitopes on wild-type and mutant beta-(1-->4)-galactosyltransferase-1. Carbohydrate Research. 313: 37-48. PMID 9861700 DOI: 10.1016/S0008-6215(98)00247-X  0.381
1998 Burda P, Borsig L, de Rijk-van Andel J, Wevers R, Jaeken J, Carchon H, Berger EG, Aebi M. A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. The Journal of Clinical Investigation. 102: 647-52. PMID 9710431 DOI: 10.1172/Jci2266  0.407
1998 Lemaire S, Derappe C, Pasqualetto V, Mrkoci K, Berger EG, Aubery M, Neel D. T Lymphocyte activation results in an increased expression of β-1,4-Galactosyltransferase: Phorbol ester induces a similar enhancement in the absence of mitosis Glycoconjugate Journal. 15: 161-168. PMID 9557876 DOI: 10.1023/A:1006968206257  0.331
1998 Mrkoci Felner K, Dinter A, Cartron JP, Berger EG. Repressed β-1,3-galactosyltransferase in the Tn syndrome Biochimica Et Biophysica Acta - Molecular Basis of Disease. 1406: 115-125. PMID 9545556 DOI: 10.1016/S0925-4439(97)00090-2  0.336
1998 Berger EG, Burger P, Borsig L, Malissard M, Felner KM, Zeng S, Dinter A. Immunodetection of glycosyltransferases: prospects and pitfalls. Advances in Experimental Medicine and Biology. 435: 119-32. PMID 9498071 DOI: 10.1007/978-1-4615-5383-0_12  0.359
1998 Borsig L, Katopodis AG, Bowen BR, Berger EG. Trafficking and localization studies of recombinant α1,3-fucosyltransferase VI stably expressed in CHO cells Glycobiology. 8: 259-268. PMID 9451035 DOI: 10.1093/Glycob/8.3.259  0.386
1998 Hennet T, Dinter A, Kuhnert P, Mattu TS, Rudd PM, Berger EG. Genomic cloning and expression of three murine UDP-galactose: beta-N-acetylglucosamine beta1,3-galactosyltransferase genes. The Journal of Biological Chemistry. 273: 58-65. PMID 9417047 DOI: 10.1074/Jbc.273.1.58  0.661
1997 Borsig L, Berger EG, Malissard M. Expression and purification of His-tagged beta-1,4-galactosyltransferase in yeast and in COS cells. Biochemical and Biophysical Research Communications. 240: 586-9. PMID 9398608 DOI: 10.1006/Bbrc.1997.7706  0.403
1997 Zeng S, Dinter A, Eisenkrätzer D, Biselli M, Wandrey C, Berger EG. Pilot Scale Expression And Purification Of Soluble Protein A Tagged Beta 1,6N-Acetylglucosaminyltransferase In Cho Cells Biochemical and Biophysical Research Communications. 237: 653-658. PMID 9299421 DOI: 10.1006/Bbrc.1997.7209  0.411
1997 Coughlan CM, Burger PG, Berger EG, Breen KC. The biochemical consequences of α2,6(N) sialyltransferase induction by dexamethasone on sialoglycoprotein expression in the rat H411e hepatoma cell line Febs Letters. 413: 389-393. PMID 9280318 DOI: 10.1016/S0014-5793(97)00923-X  0.37
1997 Felner KM, Niederer E, Berger EG. Flow cytometric detection of the Golgi apparatus using antibodies to glycosyltransferases Cytometry. 28: 50-57. PMID 9136755 DOI: 10.1002/(Sici)1097-0320(19970501)28:1<50::Aid-Cyto6>3.0.Co;2-L  0.315
1997 Martinez O, Antony C, Pehau-Arnaudet G, Berger EG, Salamero J, Goud B. GTP-bound forms of rab6 induce the redistribution of Golgi proteins into the endoplasmic reticulum Proceedings of the National Academy of Sciences of the United States of America. 94: 1828-1833. PMID 9050864 DOI: 10.1073/Pnas.94.5.1828  0.333
1996 Mrkoci K, Kelm S, Crocker PR, Schauer R, Berger EG. Constitutively hyposialylated human T-lymphocyte clones in the Tn-syndrome: binding characteristics of plant and animal lectins Glycoconjugate Journal. 13: 567-573. PMID 8872113 DOI: 10.1007/Bf00731444  0.308
1996 Malissard M, Borsig L, Di Marco S, Grütter MG, Kragl U, Wandrey C, Berger EG. Recombinant soluble beta-1,4-galactosyltransferases expressed in Saccharomyces cerevisiae. Purification, characterization and comparison with human enzyme. European Journal of Biochemistry / Febs. 239: 340-8. PMID 8706738 DOI: 10.1111/J.1432-1033.1996.0340U.X  0.354
1995 Dinter A, Berger EG. The Regulation of Cell-and Tissue-Specific Expression of Glycans by Glycosyltransferases Advances in Experimental Medicine and Biology. 376: 53-82. PMID 8597263 DOI: 10.1007/978-1-4615-1885-3_6  0.311
1995 Herrmann GF, Krezdorn C, Malissard M, Kleene R, Paschold H, Weuster-Botz D, Kragl U, Berger EG, Wandrey C. Large-scale production of a soluble human beta-1,4-galactosyltransferase using a Saccharomyces cerevisiae expression system. Protein Expression and Purification. 6: 72-8. PMID 7756841 DOI: 10.1006/Prep.1995.1010  0.384
1995 Borsig L, Ivanov SX, Herrmann GF, Kragl U, Wandrey C, Berger EG. Scaled-Up Expression of Human α2,6(N)Sialyltransferase in Saccharomyces cerevisiae Biochemical and Biophysical Research Communications. 210: 14-20. PMID 7741734 DOI: 10.1006/Bbrc.1995.1621  0.378
1995 Herrmann GF, Elling L, Krezdorn CH, Kleene R, Berger EG, Wandrey C. Use of transformed whole yeast cells expressing β-1,4-galactosyltransferase for the synthesis of N-acetyllactosamine Bioorganic & Medicinal Chemistry Letters. 5: 673-676. DOI: 10.1016/0960-894X(95)00093-9  0.33
1994 Kleene R, Krezdorn CH, Watzele G, Meyhack B, Herrmann GF, Wandrey C, Berger EG. Expression of Soluble Active Human β1,4 Galactosyltransferase in Saccharomyces cerevisiae Biochemical and Biophysical Research Communications. 201: 160-167. PMID 8198570 DOI: 10.1006/Bbrc.1994.1683  0.358
1994 Krezdorn CH, Kleene RB, Watzele M, Ivanov SX, Hokke CH, Kamerling JP, Berger EG. Human β1,4 galactosyltransferase and α2,6 sialyltransferase expressed in Saccharomyces cerevisiae are retained as active enzymes in the endoplasmic reticulum Febs Journal. 220: 809-817. PMID 8143735 DOI: 10.1111/J.1432-1033.1994.Tb18683.X  0.408
1994 Berger EG, Thurnher M, Dinter A. The cell-specific expression of glycan antigens exemplified by the deficiency of β1,3 galactosyltransferase in the Tn-syndrome Transfusion Clinique Et Biologique. 1: 103-108. PMID 8019643 DOI: 10.1016/S1246-7820(94)80004-9  0.311
1993 Krezdorn CH, Watzele G, Kleene RB, Ivanov SX, Berger EG. Purification and characterization of recombinant human β1–4 galactosyltransferase expressed in Saccharomyces cerevisiae Febs Journal. 212: 113-120. PMID 8444150 DOI: 10.1111/J.1432-1033.1993.Tb17640.X  0.393
1993 Thurnher M, Clausen H, Sharon N, Berger EG. Use of O-glycosylation-defective human lymphoid cell lines and flow cytometry to delineate the specificity of Moluccella laevis lectin and monoclonal antibody 5F4 for the Tn antigen (GalNAcα1-O-Ser/Thr) Immunology Letters. 36: 239-243. PMID 8370596 DOI: 10.1016/0165-2478(93)90095-J  0.341
1993 Berger EG, Grimm K, Bächi T, Bosshart H, Kleene R, Watzele M. Double immunofluorescent staining of α2,6 sialyltransferase and β1,4 galactosyltransferase in monensin‐treated cells: Evidence for different Golgi compartments? Journal of Cellular Biochemistry. 52: 275-288. PMID 7690043 DOI: 10.1002/Jcb.240520304  0.31
1993 Thurnher M, Rusconi S, Berger EG. Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. Journal of Clinical Investigation. 91: 2103-2110. PMID 7683697 DOI: 10.1172/Jci116434  0.382
1992 Bosshart H, Berger EG. Biosynthesis and intracellular transport of alpha-2,6-sialyltransferase in rat hepatoma cells. Febs Journal. 208: 341-349. PMID 1521530 DOI: 10.1111/J.1432-1033.1992.Tb17192.X  0.353
1992 Thurnher M, Clausen H, Fierz W, Lanzavecchia A, Berger EG. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability. European Journal of Immunology. 22: 1835-1842. PMID 1378020 DOI: 10.1002/Eji.1830220724  0.36
1991 Bosshart H, Straehl P, Berger B, Berger EG. Brefeldin A induces endoplasmic reticulum-associated O-glycosylation of galactosyltransferase. Journal of Cellular Physiology. 147: 149-156. PMID 1903795 DOI: 10.1002/Jcp.1041470119  0.337
1990 Schneider R, Hammel M, Berger EG, Ghisalba O, Nueesch J, Gygax D. Immobilization of galactosyltransferase and continuous galactosylation of glycoproteins in a reactor. Glycoconjugate Journal. 7: 589-600. PMID 2136355 DOI: 10.1007/Bf01189079  0.35
1987 Lucocq JM, Berger EG, Roth J. Detection of terminal N-linked N-acetylglucosamine residues in the Golgi apparatus using galactosyltransferase and endoglucosaminidase F/peptide N-glycosidase F: adaptation of a biochemical approach to electron microscopy. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 35: 67-74. PMID 2432113 DOI: 10.1177/35.1.2432113  0.339
1986 Berger EG, Aegerter E, Mandel T, Hauri H. Monoclonal antibodies to soluble, human milk galactosyltransferase (lactose synthase A protein). Carbohydrate Research. 149: 23-33. PMID 3089602 DOI: 10.1016/S0008-6215(00)90366-5  0.363
1985 Berger EG, Hesford FJ. Localization of galactosyl- and sialyltransferase by immunofluorescence: evidence for different sites Proceedings of the National Academy of Sciences of the United States of America. 82: 4736-4739. PMID 3927289 DOI: 10.1073/Pnas.82.14.4736  0.391
1984 Davis BW, Berger EG, Locher GW, Zeller M, Goldhirsch A. Immunohistochemical localization of galactosyltransferase in the normal human ovary and fallopian tube. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 32: 92-6. PMID 6418792 DOI: 10.1177/32.1.6418792  0.322
1982 Verdon B, Mandel T, Berger EG, Fey H. A solid-phase ELISA for human galactosyltransferase. Journal of Immunological Methods. 55: 27-33. PMID 6818281 DOI: 10.1016/0022-1759(82)90073-4  0.316
1982 Pestalozzi DM, Hess M, Berger EG. Immunohistochemical Evidence for Cell Surface and Golgi Localization of Galactosyltransferase in Human Stomach, Jejunum, Liver and Pancreas Journal of Histochemistry and Cytochemistry. 30: 1146-1152. PMID 6815262 DOI: 10.1177/30.11.6815262  0.347
1982 Wilson JR, Weiser MM, Albini B, Schenck JR, Rittenhouse HG, Hirata AA, Berger EG. Co-purification of soluble human galactosyltransferase and immunoglobulins. Biochemical and Biophysical Research Communications. 105: 737-744. PMID 6807305 DOI: 10.1016/0006-291X(82)91496-6  0.327
1982 Roth J, Berger EG. Immunocytochemical localization of galactosyltransferase in HeLa cells: codistribution with thiamine pyrophosphatase in trans-Golgi cisternae. Journal of Cell Biology. 93: 223-229. PMID 6121819 DOI: 10.1083/Jcb.93.1.223  0.357
1981 Hesford FJ, Berger EG. Human erythrocyte galactosyltransferase. Characterization, membrane association and sidedness of active site. Biochimica Et Biophysica Acta. 649: 709-716. PMID 6797473 DOI: 10.1016/0005-2736(81)90175-9  0.325
1981 Hesford FJ, Berger EG, Eijnden DHVD. Identification of the product formed by human erythrocyte galactosyltransferase. Biochimica Et Biophysica Acta. 659: 302-311. PMID 6789880 DOI: 10.1016/0005-2744(81)90056-5  0.356
1981 Berger EG, Mandel T, Schilt U. Immunohistochemical localization of galactosyltransferase in human fibroblasts and HeLa cells. Journal of Histochemistry and Cytochemistry. 29: 364-370. PMID 6787115 DOI: 10.1177/29.3.6787115  0.307
1979 Gerber AC, Kozdrowski I, Wyss SR, Berger EG. The Charge Heterogeneity of Soluble Human Galactosyltransferases Isolated from Milk, Amniotic Fluid and Malignant Ascites Febs Journal. 93: 453-460. PMID 33805 DOI: 10.1111/J.1432-1033.1979.Tb12843.X  0.355
1978 Berger EG, Kozdrowski I, Weiser MM, Eijnden DHvd, Schiphorst WECM. Human serum galactosyltransferase: distinction, separation and product identification of two galactosyltransferase activities. Febs Journal. 90: 213-222. PMID 710425 DOI: 10.1111/J.1432-1033.1978.Tb12593.X  0.333
Show low-probability matches.